Understanding the response of these cell lines to TRAIL, chrysoeriol, and their synergistic combination could provide critical insights into overcoming resistance in RCC, paving the way for the development of more effective therapeutic strategies. Here, TNFSF10 is linked to renal cell carcinoma.